ARPA-H Awards Up to $15 Million to Seaport Therapeutics and Monash Institute to Advance First Oral Therapy Targeting Gut Lymphatic Dysfunction Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative medicines, has announced that it has been awarded up…
EU Regulatory Reforms and Global Healthcare Innovation to Be Central Focus at DIA Europe 2026 DIA, a global non-profit association of life sciences professionals, has announced that DIA Europe 2026 will convene leading voices from across Europe and around the…
National Grange Backs New Report Warning of Rural Health Funds Being Redirected to Urban Hospitals The National Grange has expressed strong support for the release of a comprehensive new analysis examining how certain Medicare hospital reclassification policies are diverting critical…
Median Technologies to Highlight eyonis® LCS at ECR 2026 as U.S. Commercial Launch Advances and European CE Marking Decision Nears Median Technologies today announced that it will showcase its AI-powered lung cancer screening solution, eyonis® LCS, at the upcoming European…
Strategic $7.65 Million Collaboration Aims to Accelerate Development of a Novel ANO5 Gene Replacement Therapy Toward Clinical Trials Cure Rare Disease (CRD), a nonprofit biotechnology organization dedicated to developing treatments for individuals with rare genetic disorders, today announced a landmark,…
MySpaLive’s Compliance and Training Framework As conversations continue across the medical aesthetics industry regarding claims that Texas has “closed a med spa loophole” in 2026, MySpaLive is issuing a detailed clarification grounded in statutory authority, legislative history, and current Texas…
SBC Medical Appoints Sheng-FU Hsiao as Chief Technology Officer to Accelerate AI-Driven Transformation SBC Medical Group Holdings Incorporated (“SBC Medical” or the “Company”), a global provider of comprehensive management and consulting services for medical institutions and clinic networks, has announced…
First Patient Dosed in Phase 1 Trial of IDE034, a Bispecific B7H3/PTK7 TOP1 ADC Why is the development of new cancer therapies so critical in today’s healthcare landscape? Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and IDEAYA…
Secure Telehealth Platform Enhances Access and Safety in Correctional Facilities Why is access to quality healthcare in correctional facilities still a pressing challenge? CFG Health, a regional provider of correctional healthcare services, is addressing this issue with the launch of…
Prothena’s Strategic Move to Boost Shareholder Confidence and Financial Flexibility Why are biotechnology companies increasingly turning to share repurchase plans to optimize their financial strategies? Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics,…
AI-Powered Cancer Diagnosis Innovator to Share Latest Developments and Milestones Why is early cancer diagnosis still a critical challenge in the healthcare industry? Median Technologies, a global leader in AI-based medical imaging and software solutions, is set to address this…
Enhancing Diagnostic Capabilities with Advanced Imaging Technology Why is the adoption of digital pathology critical for healthcare providers today? Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic pathology services based in Plainview, New York, has partnered with Azer Scientific…